The NMDA receptor and schizophrenia: from pathophysiology to treatment

DT Balu - Advances in pharmacology, 2016 - Elsevier
Schizophrenia is a severe mental illness that affects almost 1% of the population worldwide.
Even though the etiology of schizophrenia is uncertain, it is believed to be a …

NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture

J Dalmau - Neurology, 2016 - AAN Enterprises
Investigations during the last 10 years have revealed a group of disorders mediated by
antibodies against ion channels and synaptic receptors, which cause both neurologic and …

GluN2A mediates ketamine-induced rapid antidepressant-like responses

T Su, Y Lu, C Fu, Y Geng, Y Chen - Nature Neuroscience, 2023 - nature.com
Ketamine was thought to induce rapid antidepressant responses by inhibiting GluN2B-
containing N-methyl-d-aspartic acid (NMDA) receptors (NMDARs), which presents a …

NMDAR hypofunction animal models of schizophrenia

G Lee, Y Zhou - Frontiers in molecular neuroscience, 2019 - frontiersin.org
The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to
help understand the etiology and pathophysiology of schizophrenia. This hypothesis was …

Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines

F Ali, DM Gerhard, K Sweasy, S Pothula… - Nature …, 2020 - nature.com
A subanesthetic dose of ketamine causes acute psychotomimetic symptoms and sustained
antidepressant effects. In prefrontal cortex, the prevailing disinhibition hypothesis posits that …

Impaired tuning of neural ensembles and the pathophysiology of schizophrenia: a translational and computational neuroscience perspective

JH Krystal, A Anticevic, GJ Yang, G Dragoi… - Biological …, 2017 - Elsevier
The functional optimization of neural ensembles is central to human higher cognitive
functions. When the functions through which neural activity is tuned fail to develop or break …

Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia

E Parellada, P Gassó - Translational psychiatry, 2021 - nature.com
Schizophrenia disorder remains an unsolved puzzle. However, the integration of recent
findings from genetics, molecular biology, neuroimaging, animal models and translational …

[HTML][HTML] A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link …

VS Catts, YL Lai, CS Weickert, TW Weickert… - Biological psychology, 2016 - Elsevier
Evidence suggests that anomalous mismatch negativity (MMN) in schizophrenia is related to
glutamatergic abnormalities, possibly involving N-methyl-d-aspartate (NMDA) receptors …

Abnormal gamma oscillations in N-methyl-D-aspartate receptor hypofunction models of schizophrenia

MP Jadi, MM Behrens, TJ Sejnowski - Biological Psychiatry, 2016 - Elsevier
N-methyl-D-aspartate receptor (NMDAR) hypofunction in parvalbumin-expressing (PV+)
inhibitory neurons (INs) may contribute to symptoms in patients with schizophrenia (SZ). This …

Alterations of auditory-evoked gamma oscillations are more pronounced than alterations of spontaneous power of gamma oscillation in early stages of schizophrenia

M Tada, K Kirihara, D Koshiyama, T Nagai… - Translational …, 2023 - nature.com
Several animal models of schizophrenia and patients with chronic schizophrenia have
shown increased spontaneous power of gamma oscillations. However, the most robust …